🔥🔥 #WeTheTeamIBD 👍🏽@ClevelandClinic hire only THE BEST. Announcing the recruitment of Dr. Joseph Sleiman (@JosephHabibi_MD) as Advanced #IBD fellow 2024/25. Welcome! So good for us! @MRegueiroMD @tqaziMD @HolubarStefan @KatieFalloonMD @SuhaAbushamma @IBDBen @tinahamd 🔥🔥
Florian Rieder MD
10.9K posts
Shaker Heights, OH
Joined December 2018
- Congratulations @MRegueiroMD for being appointed the new chair of the @ClevelandClinic Digestive Diseases and Surgery Institute. Bright future ahead! @beridgeway @TomMihaljevicMD @MagedRizkMD @IBDMD @ibddocmaria @doc_ibd @IBD_Afzali @tinahamd @DrsMeena @ownyourcrohnsCongratulations to @MRegueiroMD for being selected as the next Digestive Diseases and Surgery Institute chair! Can’t imagine a better leader for our future. @IBD_FloMD @JPAchkarMD @IBDBen @tqaziMD @ClevelandClinic
- I recommend the #COVID19 vaccine to my #IBD patients when offered. While the #IBD population was not specifically investigated in the vaccine trials there is no signal or concern The risks of #COVID19 infection far outweighs the vaccine risk. @GutlessGlamour @ownyourcrohns
- 👉🏽👉🏻👉🏿Thrilled to announce that Dr. Suha Abushamma (@SuhaAbushamma) will join @ClevelandClinic #WeTheTeamIBD👍 as a staff member in summer 2023! Amazing addition and BIG win. Welcome! @MRegueiroMD @JPAchkarMD @JessPhilpottMD @ManuelBragaMD @tqaziMD @IBDBen @HolubarStefan
- Congratulations to your graduation from #IBD fellowship @SuhaAbushamma & @KatieFalloonMD. Truly honored to have been part of your journey. You are amazing! @SaraElOualiMD @MRegueiroMD @ScottRSteeleMD @tinahamd @DrsMeena @Marylandibddoc @MLongMD @HorstIBDDoc @DCharabaty @tqaziMD
- Happy day!Big congrats to @IBD_FloMD for award of his first #R01 to investigate the mechanisms of #fibrosis and stricture formation in #CrohnsDisease! Instead of focusing on immune cell function, he will study fat cell metabolism's role in disease pathology: tinyurl.com/y4n6jslb
- 🔥🔥Stricturing Crohn’s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions🔥🔥Thank you @AGA_Gastro for highlighting our work!! Let us show you the major findings in below 🧵 1/6 @MRegueiroMD
- U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis | Business Wire businesswire.com/news/home/2023…
- All female (almost…) GI consult team. Great job last week. If was fun working with all ⭐️s. @HelenePuzio @JoyMongYates @KatieFalloonMD @cmaruggi @RobertoSimonsMD @ChahalPrabhleen @CLindenmeyerMD
- 👋🏽👋🏿👋🏻 Warm welcome to @MichelleKimMD (Prof. Michelle Kim) as the incoming Chair of Gastroenterology, Hepatology and Nutrition @ClevelandClinic. We are all looking forward to working with you. Onwards and upwards! 👋🏿👋🏻👋🏽 @MRegueiroMD @MagedRizkMD @ChahalPrabhleen @RobertoSimons
- Welcome to our new @ClevelandClinic Advanced #IBD Fellow @RuthvikPadival (Dr. Vik Padival), star gastroenterologist and budding psychiatrist, excellent expertise at the med-psych interface in #IBD. Honored to have you as part of our team! @MRegueiroMD @ConorDelaneyMD @IBDBen
- 🔥🔥News from #WeTheFibrosisLab🔬 #STARConsortium🔥🔥Thank you @AGA_Gastro for highlighting our work on the role of creeping fat derived free fatty acids on stricturing Crohn's disease gastrojournal.org/article/S0016-…. Check it out. A thread 🧵 (1/7) @MRegueiroMD @JosephHabibi_MD
- Congratulations @SaraElOualiMD for graduation from @ClevelandClinic #IBD fellowship! Your are a ⭐️. We will miss you and your wonderful family! Save travels to @CCAD. @JPAchkarMD @HolubarStefan @JessPhilpottMD @MRegueiroMD @ConorDelaneyMD @drtracyhull @IBDBen #WeTheTeamIBD👍
- ⭐️⭐️ News from #WeTheFibrosisLab ⭐️⭐️⭐️ Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions biorxiv.org/content/10.110… Check out the 🧵 for the major findings 👇🏽👇🏿👇🏻 @MRegueiroMD @HolubarStefan @tinahamd 1/6















